Nippi

Basic Information

Stock Code
7932
Industry
Other Products
Category Detail
Food Manufacturing
Prefecture
Tokyo
Establishment Year
April 1907
Listing Year
June 1963
Official Website
https://www.nippi-inc.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Kikkoman, Ajinomoto, S&B Foods, House Foods Group, Sato Food Industries, Ariake Japan, Taiyo Chemical, Fuso Chemical Industry, Riken Vitamin, Hasegawa Fragrances, Sanyo Kogyo, Shinka Kogyo, DMS

Overview

Nippi is a major manufacturer of leather, gelatin, and collagen founded in 1907, and a comprehensive biomaterial company strong in pharmaceutical materials and regenerative medicine.

Current Situation

In fiscal 2018, Nippi achieved consolidated sales of 42.1 billion yen and ordinary income of 1.8 billion yen, maintaining steady business with food-grade gelatin and pharmaceutical collagen at its core. In its mainstay leather business, it continues to produce leather for shoes, with high technological capabilities as the source of its competitiveness. It is diversifying into regenerative medicine and peptide businesses, developing pharmaceutical test kits and functional foods. It has major bases domestically and internationally, has obtained ISO certifications for quality control and manufacturing technology to ensure reliability, and is advancing ESG measures such as sustainable raw material procurement and reduction of environmental impact. In the future, it positions new material development using bio-technology and overseas market expansion as key strategies. Its board structure is stable, focusing on strengthening its medium- to long-term management foundation. In recent years, backed by the expanding market for collagen cosmetics and health foods, it is strengthening new product launches to aim for business growth.

Trivia

Interesting Facts

  • Long-established company with over 100 years of history originating from Tokyo Seihi
  • Rare company balancing leather manufacturing and bio-material production
  • Mutual top shareholder relationship with Regal Corporation
  • Holds high share in domestic gelatin raw material market
  • Acquired ISO9001 and European Pharmacopoeia-compliant high-quality standards
  • Industry top-class in collagen materials for regenerative medicine
  • Major player in bovine spongiform encephalopathy test kit market
  • Advances cutting-edge research through Biomatrix Laboratory
  • Diversified expansion from food to medical and cosmetics
  • Characterized by fusion of traditional and cutting-edge bio-technology
  • Welcomed Shibusawa Eiichi as advisor among founding executives
  • One of the first companies to introduce ISO standard certifications
  • Possesses wide product lineup including chemical products
  • Contributes to local economy with headquarters in Adachi Ward since founding
  • Continues stable supply of leather to domestic and international shoe manufacturers

Hidden Connections

  • Strong connection as mutual top shareholders with Regal Corporation
  • Leather manufacturing technology applied to high-function raw material development in cosmetics industry
  • Biomatrix Laboratory collaborates with local medical institutions and universities
  • Stably supplies pharmaceutical gelatin to pharmaceutical companies, becoming industry standard
  • One of Japan's long-established conglomerates developed from integration of Okuragumi leather factories
  • Test kit technology contributes to hygiene management in domestic livestock industry
  • Some cosmetic raw materials derived from natural sources through collaboration with local aquaculture
  • Multiple ISO9001-certified factories domestically and internationally implementing world-standard quality assurance

Future Outlook

Growth Drivers

  • Increasing collagen demand due to rising health consciousness
  • New products and technologies in regenerative medicine
  • Expansion of food additives and functional food markets
  • Strengthening of natural trends in cosmetics market
  • Growing global demand for pharmaceutical materials
  • Extension of demand for environmentally responsive products
  • Technological evolution in biomaterial research
  • Stable demand in domestic leather market
  • Improved production efficiency through digital technology utilization
  • Enhanced corporate value through ESG strengthening
  • Business expansion via new partnerships and alliances
  • Market first-mover advantage from next-generation material development success

Strategic Goals

  • Breakthrough of 10 billion yen in sales of regenerative medicine products
  • Achieve 50% environmental impact reduction targets
  • Expand overseas sales ratio to 30%
  • Continue and expand acquisition of international certifications such as ISO9001
  • Strengthen differentiation through market launch of new collagen products
  • Diversify B2B business and acquire new customers
  • Improve transparency of sustainability reports
  • Maintain R&D expenses at over 5% of annual sales
  • Strengthen stable supply system for food and pharmaceutical materials
  • Promote diversity among employees and advance work-style reforms

Business Segments

Food Material Manufacturing

Overview
Supplies safe, high-quality gelatin and collagen materials for food and beverages.
Competitiveness
High-purity manufacturing technology and pharmaceutical-level quality control
Customers
  • Food Processors
  • Confectionery Manufacturers
  • Health Food Companies
  • Beverage Manufacturers
  • Cosmetics Manufacturers
Products
  • Gelatin Raw Materials
  • Collagen Peptides
  • Functional Food Materials
  • Health Supplement Raw Materials
  • Food Additives

Medical and Regenerative Medicine Materials

Overview
Provides high-functionality bio-materials for pharmaceuticals and regenerative medicine.
Competitiveness
High value-added medical materials and advanced R&D capabilities
Customers
  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • Regenerative Medicine Institutions
  • Research Institutions
Products
  • Pharmaceutical Gelatin
  • Medical Collagen
  • Cell Culture Materials
  • Test Kits
  • Regenerative Medicine Biomaterials

Leather Product Sales

Overview
Supplies a wide range of materials centered on high-quality leather for shoes.
Competitiveness
High-quality leather manufacturing based on traditional technology and environmental considerations
Customers
  • Shoe Manufacturers
  • Bag Manufacturers
  • Apparel Manufacturers
  • Furniture Manufacturers
Products
  • Natural Leather
  • Synthetic Leather
  • Leather Processing Agents
  • Finishing Agents

Chemical Product Supply

Overview
Provides chemical products for leather processing and various industrial applications.
Competitiveness
Specialized technology and wide product lineup
Customers
  • Leather Processors
  • Industrial Product Manufacturers
Products
  • Leather Chemicals
  • Linkers
  • Various Chemical Agents

Health and Beauty Product Development Support

Overview
Supports materials and R&D for consumer health and beauty products.
Competitiveness
Advanced biotechnology and market-oriented product development
Customers
  • Cosmetics Companies
  • Health Food Manufacturers
  • R&D Institutions
Products
  • Basic Cosmetic Raw Materials
  • Functional Peptides
  • High-Moisturizing Ingredients

Test and Analysis Kit Sales

Overview
Provides high-precision test kits for livestock and medical applications.
Competitiveness
High-sensitivity technology and extensive track record of adoption
Customers
  • Agricultural Organizations
  • Medical Institutions
  • Livestock Producers
Products
  • Bovine Spongiform Encephalopathy Test Kit
  • Various Analysis Equipment

Competitive Advantage

Strengths

  • High technological capabilities based on long history
  • Diverse biomaterial product lineup
  • Strict quality control system
  • Reliability from ISO certifications
  • Expertise in pharmaceutical materials
  • Strong position in domestic leather market
  • Active investment in R&D
  • Stable major shareholder composition
  • Diverse sales channel deployment
  • Excellent research capabilities of Biomatrix Laboratory
  • Pioneering entry into regenerative medicine
  • Wide product lineup
  • Development capabilities in functional food materials
  • Extensive network of domestic production bases
  • Provision of environmentally friendly products

Competitive Advantages

  • Market leadership in high-purity gelatin for pharmaceuticals and food
  • Fusion of traditional leather manufacturing technology and advanced synthetic leather
  • Advanced initiatives in bio-medical material development
  • Management stability through diversified business
  • Product lineup capable of meeting domestic and international bio-material needs
  • Strong corporate governance and management team
  • Business promotion through collaboration with major shareholders
  • Quality assurance via ISO9001 and European Pharmacopoeia compliance
  • High-precision products in medical and test kit markets
  • Commitment to sustainable resource procurement
  • Technological innovation by skilled R&D team
  • One of the few companies successful in commercializing regenerative medicine materials
  • Broad customer base and long-term transaction record
  • Steady expansion into cosmetics and health food markets
  • Market risk diversification through product diversity

Threats

  • Risk of raw material price fluctuations
  • Maturing domestic market and intensifying competition
  • Impact of global regulatory tightening
  • Competition from advancing alternative material technologies
  • Potential cost increases due to exchange rate fluctuations
  • Price competition from emerging country manufacturers
  • Rising manufacturing costs due to environmental regulations
  • Supply chain disruption risks from pandemics, etc.
  • Development delays due to engineer shortages
  • Rapid changes in consumer needs
  • Intellectual property infringement risks
  • Risks in stable supply of animal raw materials

Innovations

2024: Commercialization of Biomaterials for Regenerative Medicine

Overview
Commercialized high-functionality collagen materials used as cell culture substrates.
Impact
Established new revenue source through supply to medical institutions

2023: New Development of Functional Peptides

Overview
Succeeded in R&D of peptides with immune-modulating effects.
Impact
Contributes to product differentiation in health food market

2022: Advanced Automation of Pharmaceutical Gelatin Manufacturing Process

Overview
Advanced digitalization and automation of production lines for efficiency.
Impact
Achieved 10% reduction in manufacturing costs and uniform quality

2021: Introduction of Sustainable Raw Material Procurement System

Overview
Enhanced traceability of animal by-products and promoted environmental considerations.
Impact
Improved ESG evaluation and gained market trust

2020: Launch of New BSE Test Kit Model

Overview
Introduced improved product achieving shorter testing time and higher sensitivity.
Impact
Expanded sales and improved customer satisfaction

Sustainability

  • Enhanced traceability of animal-derived raw materials
  • Introduction of advanced wastewater purification systems at factories
  • Waste reduction and recycling promotion activities
  • Review of manufacturing processes to reduce environmental impact
  • Active participation in local environmental conservation activities
  • Strengthened chemical substance management for safety
  • Sustainability assessments in supply chain
  • Regular training to raise employee environmental awareness
  • Accelerated investment in energy-saving equipment
  • Ensuring transparency through regular environmental report publication
  • Support for biodiversity conservation activities
  • Expansion of biomass utilization